Press Release

Usa, Serbia, Morocco and Indonesia: Catania, world capital of Harm Reduction

27 February 2023

27th February: Replica 2.0 Kick-off meeting

9 February 2023

Replica: slight or no cytotoxic, mutagenic and genotoxic effects induced by the ecig aerosol

7 November 2022

5th Scientific Summit in Athens: success for the Replica project

22 September 2022

Impact of ENDS on oxidative stress: a Replica project review

21 September 2022

Replica project results at the XVI FISV Congress in Naples

8 September 2022

Replica Project at the Scientific Summit on Tobacco Harm Reduction

5 September 2022

Replica Project: switching to ecig can restore vascular system repair mechanisms

26 July 2022

Replica project: Temple University features a lecture by Massimo Caruso

6 April 2022

Experimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project

4 April 2022

No more doubts: e-cigs are less toxic than traditional cigarettes

17 December 2021

Prof. Caruso, from CoEHAR, joined CORESTA SSPT2021 Conference

26 October 2021

Smoking, experts: “Alternative products reduce the harm and help those who wants to quit smoking”

4 October 2021

ECIG: a new study by CoEHAR screens different lab tests to evaluate the potential risk

30 July 2021

REPLICA announces its third Harmonization Meeting

18 May 2021

Replica (CoEHAR): is there any correlation between Covid-19 and Harm Reduction?

13 April 2021

Replica Project: a new study sets quality standards for the storage conditions of nicotine samples

13 April 2021

COVID-19 and the human body: nicotine as a “controller” of the molecular expression of ACE-2

22 February 2021

CoEHAR’s research awarded on SRNT 2021 annual meeting

18 January 2021

CoEHAR research set new guidelines for the dosage of nicotine in liquids

16 September 2020